CryoLife establishes sales force in Germany:
This article was originally published in Clinica
Biomaterial and biosurgical device specialist CryoLife (Kennesaw, Georgia) has set up a direct sales force in Freiburg, Germany, through its European subsidiary, CryoLife Europa. The team will focus on sales of CryoLife's BioGlue, a surgical adhesive product, and the distribution of its allograft tissues. It is the company's second direct sales force outside the US after its UK-based team, and will operate in the Southern and Northeast regions of Germany, including Berlin, Hamburg and Leipzig. The company is looking to spread operations to Western Germany by the end of 2007.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.